Back to Rifaxa Tablet

Rifaxa Tablet Side Effects in Pakistan

Rifaxa Tablet ke side effects ke baare mein complete guide. Common effects se le kar serious warnings tak — sab kuch is page par maujood hai.

Compiled by the PakVita Editorial Team · AI-assisted drafting with editorial review · Sourced from DRAP, WHO, BNF · Last updated:

Side Effects

Quick Answer

Common side effects of Rifaxa Tablet include abdominal discomfort and nausea. Serious effects such as breathing issue require immediate medical attention. Most patients tolerate Rifaxa Tablet well at the correct dose. Contact your doctor if any side effect persists or worsens.

Side Effects at a Glance

Common

  • Abdominal discomfort
  • Nausea
  • Headache

Serious — See a Doctor

  • Breathing issue
  • Fainting
  • Severe swelling

When to See a Doctor Immediately

  • Severe stomach pain
  • Persistent nausea or vomiting
  • Allergic reaction symptoms

Rifaxa Tablet Side Effects (Nuksanat)

Rifaxa Tablet (Rifaximin) is generally safe when taken at the correct dose. However, like all medicines, it can cause side effects in some patients.

Common Side Effects (Aam Nuksanat)

  • Abdominal discomfort
  • Nausea
  • Headache

Yeh side effects aam tor par mild hote hain. Agar yeh continue karein to doctor ko bataein.

Serious Side Effects (Sanjeedah Nuksanat)

  • Breathing issue — foran doctor se milein
  • Fainting — foran doctor se milein
  • Severe swelling — foran doctor se milein

When to See a Doctor (Kab Doctor Se Milna Zaroori Hai)

  • Severe stomach pain
  • Persistent nausea or vomiting
  • Allergic reaction symptoms

Warnings and Precautions (Ihtiyat)

  • Avoid if allergic to rifaximin or other antibiotics
  • Severe liver impairment patients should not use this medicine

Side Effects Summary Table

TypeSide EffectAction
CommonAbdominal discomfortMonitor / inform doctor
CommonNauseaMonitor / inform doctor
CommonHeadacheMonitor / inform doctor
SeriousBreathing issueForan doctor se milein
SeriousFaintingForan doctor se milein

Reporting Side Effects

Agar koi unexpected side effect nazar aaye, toh DRAP ke pharmacovigilance portal par report karein: https://www.dra.gov.pk/pharmacovigilance

Is guide ki maloomat sirf educational purpose ke liye hai. Koi bhi side effect nazar aane par doctor ya pharmacist se rabta karein.

Frequently Asked Questions

What are the most common side effects of Rifaxa Tablet?

The most commonly reported side effects of Rifaxa Tablet include abdominal discomfort and nausea. These are usually mild and go away on their own. Inform your doctor if they persist.

Can Rifaxa Tablet cause allergic reactions?

Yes, like all medicines, Rifaxa Tablet can cause allergic reactions in some people. Signs include rash, itching, swelling, or difficulty breathing. Stop use and seek medical help immediately if this happens.

Is Rifaxa Tablet safe to take for a long time?

Long-term safety depends on the condition and the patient. Your doctor will monitor for any signs of breathing issue if continued use is needed.

What should I do if I experience side effects from Rifaxa Tablet?

For mild side effects, inform your pharmacist. For serious effects such as breathing issue, stop the medicine and contact your doctor immediately or go to the nearest hospital.

Does Rifaxa Tablet affect the liver or kidneys?

Rifaxa Tablet may require dose adjustment in patients with liver or kidney impairment. Your doctor will advise based on your test results and overall health condition.

Brand alternatives, same-class options, and other medicines used for the same conditions as Rifaxa Tablet.

Sources

  1. DRAP Registered Products Database Drug Regulatory Authority of Pakistan
  2. WHO Model List of Essential Medicines, 23rd ed. (2023) World Health Organization
  3. British National Formulary (BNF) BMJ Group & Pharmaceutical Press

Medical disclaimer

This page is for educational use only and does not replace professional medical advice. Always confirm diagnosis, dose, and interactions with a qualified doctor or pharmacist before starting or changing any medicine.